Alector, Inc. (ALEC)
After hours:
| Previous close | 5.44 |
| Open | 5.48 |
| Bid | 5.39 x 400 |
| Ask | 5.43 x 200 |
| Day's range | 5.32 - 5.59 |
| 52-week range | 3.66 - 9.06 |
| Volume | |
| Avg. volume | 605,843 |
| Market cap | 524.332M |
| Beta (5Y monthly) | 0.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.38 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.75 |
Simply Wall St.Here's Why We're Watching Alector's (NASDAQ:ALEC) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
GlobeNewswireAlector to Participate in Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference (Las Vegas, Nevada) Tuesday, May 14, 2024, at 8:55 a.m. PT, corporate presentation H.C. Wainwright 2nd Annual BioConnect Investor Conference (New York, New York) Monday, May 20, 2024, at 11:00
ZacksAlector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
Alector (ALEC) delivered earnings and revenue surprises of 20.83% and 8.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
